Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Glucocorticoids target the CXCL9/CXCL10-CXCR3 axis and confer protection against immune-mediated kidney injury
Jan-Hendrik Riedel, Lennart Robben, Hans-Joachim Paust, Yu Zhao, Nariaki Asada, Ning Song, Anett Peters, Anna Kaffke, Alina Borchers, Gisa Tiegs, Larissa Seifert, Nicola M. Tomas, Elion Hoxha, Ulrich O. Wenzel, Tobias B. Huber, Thorsten Wiech, Jan-Eric Turner, Christian F. Krebs, Ulf Panzer
Jan-Hendrik Riedel, Lennart Robben, Hans-Joachim Paust, Yu Zhao, Nariaki Asada, Ning Song, Anett Peters, Anna Kaffke, Alina Borchers, Gisa Tiegs, Larissa Seifert, Nicola M. Tomas, Elion Hoxha, Ulrich O. Wenzel, Tobias B. Huber, Thorsten Wiech, Jan-Eric Turner, Christian F. Krebs, Ulf Panzer
View: Text | PDF
Research Article Immunology Nephrology

Glucocorticoids target the CXCL9/CXCL10-CXCR3 axis and confer protection against immune-mediated kidney injury

  • Text
  • PDF
Abstract

Glucocorticoids remain a cornerstone of therapeutic regimes for autoimmune and chronic inflammatory diseases — for example, in different forms of crescentic glomerulonephritis — because of their rapid antiinflammatory effects, low cost, and wide availability. Despite their routine use for decades, the underlying cellular mechanisms by which steroids exert their therapeutic effects need to be fully elucidated. Here, we demonstrate that high-dose steroid treatment rapidly reduced the number of proinflammatory CXCR3+CD4+ T cells in the kidney by combining high-dimensional single-cell and morphological analyses of kidney biopsies from patients with antineutrophil cytoplasmic antibody–associated (ANCA-associated) crescentic glomerulonephritis. Using an experimental model of crescentic glomerulonephritis, we show that the steroid-induced decrease in renal CD4+ T cells is a consequence of reduced T cell recruitment, which is associated with an ameliorated disease course. Mechanistic in vivo and in vitro studies revealed that steroids act directly on renal tissue cells, such as tubular epithelial cells, but not on T cells, which resulted in an abolished renal expression of CXCL9 and CXCL10 as well as in the prevention of CXCR3+CD4+ T cell recruitment to the inflamed kidneys. Thus, we identified the CXCL9/CXCL10-CXCR3 axis as a previously unrecognized cellular and molecular target of glucocorticoids providing protection from immune-mediated pathology.

Authors

Jan-Hendrik Riedel, Lennart Robben, Hans-Joachim Paust, Yu Zhao, Nariaki Asada, Ning Song, Anett Peters, Anna Kaffke, Alina Borchers, Gisa Tiegs, Larissa Seifert, Nicola M. Tomas, Elion Hoxha, Ulrich O. Wenzel, Tobias B. Huber, Thorsten Wiech, Jan-Eric Turner, Christian F. Krebs, Ulf Panzer

×

Figure 5

The recruitment of CXCR3+ Th1 cells in murine cGN is attenuated by glucocorticoids through the dampened production of the corresponding chemokines by tubular epithelial cells.

Options: View larger image (or click on image) Download as PowerPoint
The recruitment of CXCR3+ Th1 cells in murine cGN is attenuated by gluco...
(A) Representative plots showing mean percentages of CD4+ and CD8+ T cells, respectively, and percentage CXCR3 positivity of CD4+ T cells, as well as relative chemokine receptor expression of CD3+CD4+ T cells obtained from nephritic animals at day 10 of cGN determined by flow cytometric analyses. (B) Analysis of the single-cell RNA-Seq data of renal CD3+ T cells of nephritic mice analyzed for relative chemokine receptor expression of the CD4_naive and CD4_memory clusters. (C and D) Schematic representation of the experimental setup, and quantification of flow cytometric analyses of absolute numbers of CD3+CD4+IFN-γ+ T cells isolated from kidneys of untreated and steroid-treated nephritic mice. (E) Reverse transcription PCR (RT-PCR) analyses of indicated mRNA expression from whole renal cortices of kidneys collected from the groups mentioned before. (F) RNA scope analyses show the preferential localization of Cxcl9 and Cxcl10 mRNA to the tubulointerstitial compartment and markedly reduced expression in steroid treated mice. Scale of images is indicated by 1 cm in width equaling 15 µm. (G) Heatmap of chemokine protein levels in supernatants of proximal tubular epithelial cells after stimulation with either medium alone, IL-17A, IFN-γ, or TNF-α under increasing concentrations of prednisolone. (H and I) Schematic representation of the experimental setup, and numbers of recovered renal CD4+ T cells from PBS-treated and steroid- pulsed nephritic Rag1–/– mice after eleven days following i.v. transfer of CXCR3–CD4+ T cells into both groups. (J) Semiquantitative analysis of intrarenal T cell numbers derived from kidney sections IHC stained for CD3 for the groups mentioned before. Symbols represent individual data points, with the mean as a bar graph. Data were analyzed using a 2-tailed t test. *P < 0.05, **P < 0.01.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts